dapagliflozin
astrazeneca
['dapaglifozin']
dapaglifozin (sglt2 inhibitor) for treatment of neutropenia due to glycogen storage disease type ib and g6pc3 congenital neutropenia - it works! as presented by jean donadieau at #ash22 novel and exciting. 
https://t.co/c7hZRxkYxy
Pediatrician & hematologist studying bone marrow failure and predisposition to MDS/AML (#GATA2 #SAMD9 #SAMD9L)